Scott M. Norberg, D.O.

Head, Solid Tumor Cellular Therapy Group
Center for Immune-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA
Bethesda, MD, United States

Scott M. Norberg, D.O., is a board certified medical oncologist and heads the Solid Tumor Cellular Therapy Program at the National Cancer Institute, Center for Cancer Research, Center for Immuno-Oncology. His research focuses on the discovery and development of novel immunotherapeutics for diseases driven by chronic HPV infection including Recurrent Respiratory Papillomatosis and HPV-associated malignancies.

Disclosure information not submitted.

Presentation(s):

• PRGN-2012, a novel HPV-Targeted Immuno-Activator, induces complete and durable responses in recurrent respiratory papillomatosis patients

  Sunday, October 12, 2025
  8:12 AM - 8:18 AM EDT